If you've been doing it all, counting calories, sweating through workouts at the gym and the scale still isn't moving, don't worry. For a lot of people, weight loss has nothing to do with willpower; ...

Mounjaro (tirzepatide) is a unique injectable medication that helps to manage blood sugar levels in adults and children ages 10 and older with type 2 diabetes. Unlike many previous diabetes treatments ...

Mounjaro (tirzepatide) is a prescription drug that helps manage blood sugar levels in certain people with type 2 diabetes. It works by imitating the effects of certain hormones called incretins.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Trying to lose weight can be confusing, with so many different tips and diets out there. And that’s even before you throw in weight ...

Demand for weight loss drugs has been on the rise throughout 2025, with an estimated 1.5 million people already taking such drugs in the UK. Mounjaro is one of the major brands associated with ...

Mounjaro is a prescription drug that may be used off-label for weight loss. Learn how long it takes to start seeing results, when the drug reaches its peak effectiveness, and more. Mounjaro starts ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep. The ...

Mounjaro (tirzepatide) is a brand-name medication approved to help manage blood glucose (sugar) levels in people with type 2 diabetes. It’s used alongside lifestyle changes and physical activities.

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...